Upper airway complications of cigarette smoking

Mark A. Richardson

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Passive cigarette smoking is becoming increasingly implicated in upper respiratory tract infections. Some 9 million to 12 million children have significant exposure to cigarette smoke, which may result in pathologic changes in mucociliary transport and cellular composition of the respiratory tract. The physiologic changes related to chronic smoke exposure have been implicated as a risk factor for otitis media and bronchitis. Currently, the cellular effects of cigarette smoke or mucosa can only be reversed or eliminated with avoidance. The use of intranasal steroids or cromolyn sodium, in addition to antibiotic therapy, when an infection is present may reduce the severity or incidence of disease.

Original languageEnglish (US)
Pages (from-to)1032-1035
Number of pages4
JournalThe Journal of allergy and clinical immunology
Volume81
Issue number5 PART 2
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Smoke
Smoking
Tobacco Products
Mucociliary Clearance
Cromolyn Sodium
Tobacco Smoke Pollution
Bronchitis
Otitis Media
Respiratory Tract Infections
Respiratory System
Mucous Membrane
Steroids
Anti-Bacterial Agents
Incidence
Infection
Therapeutics

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Upper airway complications of cigarette smoking. / Richardson, Mark A.

In: The Journal of allergy and clinical immunology, Vol. 81, No. 5 PART 2, 1988, p. 1032-1035.

Research output: Contribution to journalArticle

Richardson, Mark A. / Upper airway complications of cigarette smoking. In: The Journal of allergy and clinical immunology. 1988 ; Vol. 81, No. 5 PART 2. pp. 1032-1035.
@article{91e362ebce094117b5695941039f658c,
title = "Upper airway complications of cigarette smoking",
abstract = "Passive cigarette smoking is becoming increasingly implicated in upper respiratory tract infections. Some 9 million to 12 million children have significant exposure to cigarette smoke, which may result in pathologic changes in mucociliary transport and cellular composition of the respiratory tract. The physiologic changes related to chronic smoke exposure have been implicated as a risk factor for otitis media and bronchitis. Currently, the cellular effects of cigarette smoke or mucosa can only be reversed or eliminated with avoidance. The use of intranasal steroids or cromolyn sodium, in addition to antibiotic therapy, when an infection is present may reduce the severity or incidence of disease.",
author = "Richardson, {Mark A.}",
year = "1988",
doi = "10.1016/0091-6749(88)90175-3",
language = "English (US)",
volume = "81",
pages = "1032--1035",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5 PART 2",

}

TY - JOUR

T1 - Upper airway complications of cigarette smoking

AU - Richardson, Mark A.

PY - 1988

Y1 - 1988

N2 - Passive cigarette smoking is becoming increasingly implicated in upper respiratory tract infections. Some 9 million to 12 million children have significant exposure to cigarette smoke, which may result in pathologic changes in mucociliary transport and cellular composition of the respiratory tract. The physiologic changes related to chronic smoke exposure have been implicated as a risk factor for otitis media and bronchitis. Currently, the cellular effects of cigarette smoke or mucosa can only be reversed or eliminated with avoidance. The use of intranasal steroids or cromolyn sodium, in addition to antibiotic therapy, when an infection is present may reduce the severity or incidence of disease.

AB - Passive cigarette smoking is becoming increasingly implicated in upper respiratory tract infections. Some 9 million to 12 million children have significant exposure to cigarette smoke, which may result in pathologic changes in mucociliary transport and cellular composition of the respiratory tract. The physiologic changes related to chronic smoke exposure have been implicated as a risk factor for otitis media and bronchitis. Currently, the cellular effects of cigarette smoke or mucosa can only be reversed or eliminated with avoidance. The use of intranasal steroids or cromolyn sodium, in addition to antibiotic therapy, when an infection is present may reduce the severity or incidence of disease.

UR - http://www.scopus.com/inward/record.url?scp=0023939505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023939505&partnerID=8YFLogxK

U2 - 10.1016/0091-6749(88)90175-3

DO - 10.1016/0091-6749(88)90175-3

M3 - Article

C2 - 3286730

AN - SCOPUS:0023939505

VL - 81

SP - 1032

EP - 1035

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5 PART 2

ER -